🔎 Trials Near Me

Beranda › Kanker Darah › North Carolina › Durham

Uji klinis Kanker Darah di Durham, NC

16 studi untuk Kanker Darah mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Menerima pesertaStudi observasional
  • Duke University Medical Center, Durham
Semua usia · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04242095

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Menerima pesertaFase 3
  • Duke Cancer Center ( Site 0028), Durham
  • University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Durham VA Medical Center, Durham
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Menerima pesertaFase 3
  • Quetzal Site 27, Chapel Hill · 10 mi jauhnya
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Menerima pesertaFase 1/2
  • UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi jauhnya
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT04588922

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Menerima pesertaFase 3
  • Duke University Medical Center, Durham
  • University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07007312

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Menerima peserta
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi jauhnya
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06296368

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Menerima pesertaFase 2
  • Lineberger Cancer, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06665100

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Menerima peserta
  • 2400 Pratt Street, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06532773

Implementation of an Oral Chemotherapy Adherence Intervention

Menerima peserta
  • UNC Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06989489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Duke University Medical Center, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Menerima pesertaFase 1
  • University of North Carolina, Chapel Hill · 10 mi jauhnya
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Menerima pesertaFase 1/2
  • Duke University Medical Center, Duke Cancer Center, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Menerima pesertaFase 1
  • Duke Blood Cancer Center, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT05735184

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Menerima pesertaFase awal 1
  • Duke University Health System, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT06731504

Uji klinis Kanker Darah di kota lain

Studi lain di Durham

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.